I start with my wonderful son, Joshua, losing every race at Sports Day with bravery and humour. Then, onto UK Network Agency; Innovation Agri-Tech; Eden Pharma; the wretched FCA's failure on £65 million fraud, Appbox Media/One True View; Ocado (OCDO); Morses Club (MCL); Cake Box (CBOX) - where Steve is wrong; Verditek (VDTK); and Shield Therapeutics (STX).

Specialist retailer of cream cakes Cake Box (CBOX) has announced it will publish full-year results on 27th June following an end of year audit process which has raised “an issue” in terms of the Companies Act 2006 and past dividend payments. Hmmm!

A “Trading Update” announcement from Cake Box Holdings (CBOX) commences that “the specialist retailer of fresh cream cakes, is pleased to announce a full year trading update for the 12 months ended 31 March 2022” and concludes that “with a strengthened team and investment in our operations and processes, we have all the right ingredients to continue to sustainably grow the Cake Box customer base, brand and Family”. So what of the announcement and a share price responding up to above 200p?...

This is a very long podcast, covering: Optibiotix (OPTI); Skinbiotherapeutics (SBTX); Kefi (KEFI); Bluebird (BMV); Ten Lifestyle (TENG); CakeBox (CBOX); Deepverge (DVRG); Petropavlovsk (POG); Eurasia (EUA); and Amur Minerals (AMC).

I discuss those threats and at a company level I add commentary on Nightcap (NGHT), Cake Box (CBOX) Chill Brands (CHLL), Cellular Goods (CBX) and Supply@ME Capital (SYME)

Following, in January, excellent analysis noting accounting issues by Maynard Paton and added to by Tom Winnifrith on this website, Cake Box Holdings (CBOX) played it down as “commentary from a retail investor blogger”. Now “Management Changes and Trading Update”…

I want to be 100% transparent with you so I explain why, as of 8 AM today, Peter is no longer a member of this parish after apologising for yesterday’s poor sound quality for which there was a good reason. I look at two shocking economic statistics and what they mean. I then cover: SkinBiotherapeutics (SBTX), Bluebird Merchant Ventures (BMV),  AEX Gold (AEXG), Novacyt (NCYT), Avacta (AVCT) and Cake Box (CBOX). 

Both on Friday and today shares in Cake Box (CBOX) have fallen sharply. When Maynard Paton and this website first raised questions about the accounts and other matters just three weeks ago the stock was 325p. It is now 180p. So what is going on?

A late and short bearcast. I have been distracted by news coming out about historic incidents at my old school Warwick. It is all very disturbing. In the podcast I look at Cake Box (CBOX), Amur Minerals (AMC), Novacyt (NCYT), Verditek (VDTK) and Red Rock Resources (RRR) where Andrew Bell has somemore explaining to do to we long suffering shareholders.

Today we were told that the COO of Cake Box (CBOX) had bought £50,000 of shares yesterday. Compared to the £10.5 million dump by his boss in November it is peanuts. Showing rather poor form, Dr Jaswir Singh made the purchase BEFORE rather than AFTER the company put out a weedy and patronising RNS trying to refute the bear case as explained HERE on Sunday.  Surely the good Dr was aware that a refutation was coming and thus had price sensitive information? While Dr Singh was dealing like a dervish, Lucian Miers went to visit the franchise stores in Eastleigh and Southampton. The photo below is from Eastleigh.

This podcast contains reference to various chats with Lucian on the markets, millennials and on Cake Box (CBOX) after yesterday’s bearcast & the Maynard Paton expose. I discuss what Trustpilot says about the company HERE and Lucian’s road trip to do more due diligence. Re Lucian I also discuss other big blowups that will happen this year and bitcoin. Then there is Amigo (AMGO), Chill Brands (TOAST), MyHealthchecked (MHC), Novacyt (NYCT) and Argo Blockchain (ARB) in light of today’s NFT nonsense but also the collapsing bitcoin price.

I start with a few words on Oxford Cannabinoid (OCTP). I have not said fill your boots nor should you. The issue here is management allegedly lining their own pockets ahead of corporate action which they know all about. One should not buy shares in such companies. Then I reflect on an excellent piece by Maynard Paton on Cake Box (CBOX) which you can read HERE. I comment on some of the excellent points he makes but add in half a dozen of my own, notably comparing boasted net cash and net interest costs but also the shameful CEO pump and dump and the macro headwind given the demographic of its end user base. This is probably not another Patisserie Valerie but at 320p it is a stonking short.

Earlier this month-announced half-year results from egg-free cakes retailer Cake Box Holdings (CBOX) included CEO Sukh Chamdal stating “I’m delighted to report another strong performance… it’s clear that our unique customer proposition remains highly attractive… we look ahead with confidence”. Now a shares transaction from Sukh Chamdal. Good news?…

Almost 13 months ago I observed about Cake Box (CBOX) that ‘all I have to do to complete my due diligence is…eat one of its cakes’. For a couple of reasons it did not happen, but the shares are up 4% today and up by more than 120% during the last year. That is far from shabby! But how do I feel now about the ‘Eggfree Cake’ company, where ‘having an egg free, fresh cream, celebration cake is as easy as 1,2… that’s it’?

A “Statement re Share Price Movement”-titled announcement from cakes retailer Cake Box Holdings (CBOX). That share price movement has recently been downward – from above 330p early this month to a last close 288p. With this statement also at an intra-day 10:49am, I somehow don’t expect it to be good news!…

Cake Box (CBOX) describes itself as a ‘specialist retailer of fresh cream cakes’ and has a store a few miles from where I live…not that I have troubled its doors. Whilst the company has traded positively since its 2018 IPO, the stock has had its issues above and beyond the high profile failure at Patisserie Valerie…

A “Director/PDMR Shareholding” announcement from Cake Box Holdings (CBOX) commences; “The following notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further details on the purchases”. The major transaction is though a director shares sale!…

Franchise cakes retailer Cake Box Holdings (CBOX) has updated including “by 1 June 2020, 131 of the 133 stores had reopened, offering a limited menu of products. In the last three months, since the reopening of the estate, trading has been very strong, with like-for-like sales growth of c.14.1% in franchise stores. Online sales continue to grow, up c.74% compared to the previous year three-month period” and a “decision to pay a special dividend of the same amount as the final dividend (3.2p per share) for the year ending 31 March 2020 that was withdrawn on 14 April” – and the shares have currently responded to above 180p, more than 5% higher…

Having IPO’d in 2018 at 108p per share emphasising “a franchise retailer of cakes… specialises in making high quality, individually-crafted and personalised fresh cream cakes”, Cake Box Holdings (CBOX) has now announced results for its year ended 31st March 2020 – and the shares have currently responded to 161.5p...

Newly-listed firm Cake Box (CBOX) has been making headlines, as its share price rocketed over 40% in the space of a few days since the company’s IPO last week. Meanwhile, speculation continues to mount over the specifics regarding Aston Martin’s expected IPO later in the year. With new listings making the news, we take a look this week at broker and tipster stances towards firms following their admission to the London Stock Exchange. Using IPO data going back to the beginning of 2015, we retrieved broker and tipster recommendations in the calendar year following each new listing. A “Buy” or “Risky Buy” rating is scored as a 5, a “Hold” rating as a 3 and a “Sell” or “Avoid” rating as a 1. The data throws up some interesting results, which are summarised in the two charts below.